Monthly Archives: November 2024

Landmark Australian study on oxycodone prescribing

endone 5mg

Landmark Australian study on oxycodone prescribing Oxycodone is the most prescribed strong opioid in Australia. Yet little was known about its use and prescribing patterns – until now. Marketing and prescribing of oxycodone fuelled the opioid epidemic in the United States, still raging almost 30 years after the drug was first introduced. To understand the […]

Endone 5 mg tablets

Product defect correction – potential for incorrect medicine in the pack Consumers and health professionals are advised that Aspen Pharma, in consultation with the TGA, is undertaking a product defect correction for one batch of Endone 5 mg tablets (batch number CW612, expiry November 2020). A single pack of Endone 5 mg tablets in South Australia has […]